跳至主要内容
临床试验/NCT03171610
NCT03171610已完成不适用

Randomized Double-blind Study on Efficacy of iv PCA With Fentanyl or Sufentanil in Patients Undergoing Laparoscopic Nephrectomy

Yonsei University1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2017年6月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
82
试验地点
1
主要终点
Efficacy of iv PCA with fentanyl or sufentanil in patients undergoing laparoscopic nephrectomy: Incidence of postoperative nausea and vomiting (PONV)

研究概览

简要总结

The purpose of this study is to compare the efficacy of iv PCA with fentanyl or sufentanil in patients undergoing laparoscopic nephrectomy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •patients undergoing laparoscopic or robot-assisted laparoscopic nephrectomy (total or partial)
  • •patient who want intravenous PCA for postoperative pain control

排除标准

  • •long-term use of opioid, pain reliever or tranquilizers
  • •a history of DM neuritis
  • •prolonged prothrombin time or activated partial thromboplastin time
  • •impairment of cognitive function
  • •obesity (BMI ≥ BMI 30 kg/m2)

研究组 & 干预措施

Fentanyl group

Active Comparator

PCA with fentanyl (20 mcg/kg), ramosetron (NaseaTM) 0.3 mg and ketorolac 120 mg in a normal saline with a total volume of 100ml

干预措施: Fentanyl group (Drug)

Sufentanil group

Experimental

Arm Description: PCA with sufentanil (3 mcg/kg), ramosetron (NaseaTM) 0.3 mg and ketorolac 120 mg in a normal saline with a total volume of 100ml

干预措施: Sufentanil group (Drug)

结局指标

主要结局

Efficacy of iv PCA with fentanyl or sufentanil in patients undergoing laparoscopic nephrectomy: Incidence of postoperative nausea and vomiting (PONV)

时间窗: 24 hrs after recovery room discharge

Incidence of postoperative nausea and vomiting (PONV)

次要结局

  • postoperative pain score(at arrival to recovery room, 30 minutes after arrival to recovery room, 1 hour after recovery room discharge, 6 hrs after recovery room discharge, 24 hrs after recovery room discharge)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验